NSN Co. Ltd Cash Flow Conversion Efficiency
NSN Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, NSN Co. Ltd (031860) has a cash flow conversion efficiency ratio of -0.143x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.89 Billion ≈ $-1.96 Million USD) by net assets (₩20.26 Billion ≈ $13.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NSN Co. Ltd (2014–2025)
Cash flow conversion efficiency of NSN Co. Ltd from 2014 to 2025. This chart illustrates how NSN Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NSN Co. Ltd share price for real-time trading data and today's change.
NSN Co. Ltd Cash Flow Conversion Ratio Explained
NSN Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NSN Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NSN Co. Ltd ranked by their cash flow conversion efficiency. Also see NSN Co. Ltd (031860) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vigor Kobo Co Ltd
TWO:2733
|
-0.016x |
|
Prima Globalindo Logistik Tbk
JK:PPGL
|
0.060x |
|
Park Ha Biological Technology Co., Ltd.
NASDAQ:BYAH
|
N/A |
|
IDeA Indonesia Akademi Tbk PT
JK:IDEA
|
0.034x |
|
Torrent Capital Ltd
V:TORR
|
0.075x |
|
COINSILIUM GROUP LTD
F:5CT
|
N/A |
|
Scibase AB
ST:SCIB
|
-0.457x |
|
Optimi Health Corp. Common Shares
NASDAQ:OPTH
|
-0.162x |
Annual Cash Flow Conversion Efficiency for NSN Co. Ltd (2014–2025)
The table below shows the annual cash flow conversion efficiency of NSN Co. Ltd from 2014 to 2025. Review NSN Co. Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩20.26 Billion ≈ $13.73 Million |
₩-8.86 Billion ≈ $-6.01 Million |
-0.437x | -274.65% |
| 2024-12-31 | ₩48.12 Billion ≈ $32.61 Million |
₩-5.62 Billion ≈ $-3.81 Million |
-0.117x | +12.82% |
| 2023-12-31 | ₩59.75 Billion ≈ $40.49 Million |
₩-8.00 Billion ≈ $-5.42 Million |
-0.134x | +29.67% |
| 2022-12-31 | ₩59.58 Billion ≈ $40.38 Million |
₩-11.35 Billion ≈ $-7.69 Million |
-0.190x | +40.54% |
| 2021-12-31 | ₩38.49 Billion ≈ $26.08 Million |
₩-12.33 Billion ≈ $-8.35 Million |
-0.320x | -266.26% |
| 2020-12-31 | ₩51.00 Billion ≈ $34.56 Million |
₩-4.46 Billion ≈ $-3.02 Million |
-0.087x | +54.68% |
| 2019-12-31 | ₩22.70 Billion ≈ $15.38 Million |
₩-4.38 Billion ≈ $-2.97 Million |
-0.193x | +32.29% |
| 2018-12-31 | ₩18.37 Billion ≈ $12.45 Million |
₩-5.23 Billion ≈ $-3.55 Million |
-0.285x | +29.34% |
| 2017-12-31 | ₩20.42 Billion ≈ $13.84 Million |
₩-8.24 Billion ≈ $-5.58 Million |
-0.403x | -46.84% |
| 2016-12-31 | ₩22.41 Billion ≈ $15.18 Million |
₩-6.15 Billion ≈ $-4.17 Million |
-0.275x | +1.90% |
| 2015-12-31 | ₩23.86 Billion ≈ $16.17 Million |
₩-6.68 Billion ≈ $-4.53 Million |
-0.280x | -229.13% |
| 2014-12-31 | ₩29.52 Billion ≈ $20.00 Million |
₩-2.51 Billion ≈ $-1.70 Million |
-0.085x | -- |
About NSN Co. Ltd
DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution… Read more